EAM Investors’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-64,764
Closed -$3.19M 331
2024
Q2
$3.19M Buy
+64,764
New +$2.64M 0.52% 105
2021
Q1
Sell
-15,678
Closed -$2.21M 443
2020
Q4
$2.21M Sell
15,678
-6,312
-29% -$700K 0.36% 89
2020
Q3
$1.67M Buy
+21,990
New +$1.37M 0.4% 84

Other funds holding TWST

EAM Investors's TWST Position: Q3 2024 in Review

EAM Investors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 64,764 shares — an estimated $3.19M sold.

EAM Investors first reported a position in TWST in Q3 2020 and held it in 3 quarters. The position peaked at $3.19M in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • EAM Investors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • EAM Investors sold 64,764 Twist Bioscience shares in Q3 2024, an estimated $3.19M.
  • EAM Investors first reported a position in Twist Bioscience in Q3 2020 and held it in 3 quarters.
  • EAM Investors's Twist Bioscience position peaked at $3.19M in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on EAM Investors's 13F filing for Q3 2024, filed 13 Nov 2024.